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Abstract
Background: type 2 diabetes mellitus is frequently associated with inflammatory
condition that lead to chronic complications. hs-CRP level had been reported as
markers of cardiovascular diseases (CVDs) complications. Therefore, the aim of this
study was to assess hs-CRP level in type 2 DM patients and their relation to diabetes
cardiovascular complications.
Materials and methods: In case control study (205) diagnosed type 2 DM patients
and (100) controls were included. Serum high Sensitive C Reactive Protein (hs-CRP),
Triglyceride (TG), total cholesterol (TC), high density lipoprotein (HDL-C) and low
density lipoprotein (LDL-C) were measured.
Results: Type 2 DM patients had increased level of hs-CRP and decreased HDL-C
level p-value (0.020 and 0.000) respectively. Females had increased serum hs-CRP,
TC, HDL-C and LDL-C p-value (0.005, 0.000, 0.000 and 0.000) respectively. Moreover,
patients received statin drugs showed decreases in hs-CRP, TC and LDL-C p-value
(0.030, 0.000 and 0.000) respectively. BMI correlate positively with TG (r: 0.37, P-value
0.017) and hs-CRP (r: 0.56, P-value 0.000), while it correlated negatively with HDL-C (r:
-0.36, P-value 0.029).
Conclusion: The data suggested that, hs-CRP is useful diagnostic and predictor marker
for CVDs in obese type 2 DM patients.
Keywords: High sensitive C reactive protein, cardiovascular diseases, type 2 DM,
obesity, Sudan.
1. Introduction
Diabetes mellitus (DM) is a chronic metabolic disorder, characterized by hyperglycemic
condition due to defect in secretion of insulin by β cells of pancreas or defect in insulin
action [1-3]. Recently, DM become most common chronic disorder (4) with increasing
prevalence worldwide (5). It was estimated that, 425 million people had DM in 2017,
and the number is expected to rise to 629 million by 2045 [6]. In Sudan, the prevalence
of DM is rising from 9.3% in 2010 to 10.6 % in four states in 2013 [7].
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Type 2 diabetes mellitus is a complex condition, result from resistance of insulin
action combine with impaired pancreatic function [8]. If left uncontrolled, Type 2 DM
can cause chronic microvascular and macrovascular complications [9]. Some previous
studies confirmed that, Type 2 DM gradually causes chronic low grade of inflammation
which plays vital role in the progression of diabetic complications [10].
Type 2 DM patients are at a high risk to develop CVDs and the risk increased when
patients suffer from nephropathy [11]. The CVDs are observed to increase in type 2 DM
with elevated inflammatory markers [12]. The inflammatory marker hs-CRP is pentameric
protein synthesize by hepatic cells under control of cytokines [11]. It has been identified
as a strong predictormarker for CVDs [13-15]. Previous studies documented that, diabetic
patients undergo high serum hs-CRP level [16], that lead to activation of inflammatory
pathways and progression of CVD [17, 18]. Accordingly this study was conducted to
evaluate the hypothesis that, hs-CRP is associated with CVDs in type 2 DM patients.
2. Materials and Methods
In case control study we examined n205 type 2 DM patients, (94 males and 111 females),
age ranged (from 39 to 75) years old. n100 sex and agematch health apparently subjects
were recruited as control. DM patients with inflammatory, liver and/or renal diseases
were excluded. Written inform consents were obtained from each participations. This
study was approved by local committee of Al-Neelain University, Sudan.
2.1. Measurement of BMI
Body mass index (BMI) was calculated using (weight kg/hight m2) formula.
2.2. Measurement of hs-CRP
Serum levels of hs-CRP in patients weremeasured using the Particle enhanced immuno-
turbidimetric assay method Cobas C-311®. Human CRP agglutinates with latex particles
coated with monoclonal anti-CRP antibodies, and then the precipitate was determined
turbidimmetrically.
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2.3. Measurement of lipid profile
Serum TG, TG and HDL-cholesterol were estimated by Cobas C-311® automated chem-
istry analyzer (Roche diagnostics, Germany).
2.4. TG measurement
Using the principle enzymatic colorimetric method which based on complete hydrolysis
of triglycerides by lipoprotein lipase to glycerol, followed by oxidation and peroxidation
process to form a red dyestuff. The color intensity of the red dyestuff formed is directly
proportional to the triglyceride concentration and can be measured photometrically.
2.5. TC measurement
Estimation of total cholesterol based on serial enzymatic reactions lead to formation of
red quinone-imine dye which can be measured photometrically. The color intensity of
the dye formed is directly proportional to the cholesterol concentration.
2.6. HDL-C measurement
In the presence of magnesium ions, dextran sulfate selectively forms water-soluble
complexes with LDL, VLDL and chylomicrons. The cholesterol concentration of HDL-
cholesterol is determined enzymatically after formation of a purple-blue dye. The color
intensity of this dye is directly proportional to the cholesterol concentration and is
measured photometrically.
2.7. LDL-C measurement
Levels of LDL-C were calculated using Friedwald equation as fallow:




All statistical analyses was performed using the SPSS software (Statistical Package for
the Social Sciences) (version 21.0; SPSS Inc.). Descriptive statistic (frequency and per-
centage) were obtained. Independent t-test was employed to compare mean between
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groups. Pearson’s correlation was used to correlate between study parameters and vari-
ables. Quantitative variables were demonstrated as mean ± SD, significant differences
were considered as P-value ≤ 0.05.
4. Results
The study comprised of 205 Type 2 diabetic patients, Demographic and general char-
acteristics of patients group are shown in (table 1).
The mean level of hs-CRP was significantly increased in case group (4.83 ± 0.42)
compared with control group (3.48 ± 0.38) with (p-value 0.020), while there was signif-
icant decrease in HDL-C in case (39.4 ± 8.88) compared with control (45.2 ± 12.4) with
(p-value 0.000). In addition, the mean levels of TG, TC and LDL-C showed insignificant
differences when compared case group with control group (Table 2).
The results of the study showed the mean level of hs-CRP was significantly higher in
female (5.91 ± 2.61) compared with male (3.54 ± 2.55) with (p-value 0.005). furthermore,
The lipid profile results showed significant increase in TC, HDL-C and LDL-C mean levels
in female when compared with male (p-value 0.000) and insignificant difference in mean
level of TG (table 3).
Patients group who take cholesterol lowering agent (statin) had significantly lower
levels of hs-CRP, TC and LDL-C as compared with untreated Patients (p-value 0.030,
0.000 and 0.000) respectively, while other parameter showed insignificant differences
between two groups (table 4).
In correlation analysis, hs-CRP and TG levels correlate positively with BMI (p-value
0.000 and 0.017) respectively while HDL-C inversely related with BMI (r: 0.37 p-value
0.029) as in (table 5) (Figure 1).
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Table 1: General characteristics of type 2 diabetic patients.
Characteristic Frequency (percentage %)
Gender Male: 94 (46%)
Female: 111 (54%)
Age (years) < 55 years: 96 (47%)
> 55 years: 109 (53%)
BMI Normal weight: 47 (23%)
Overweight: 94 (46%)
Obese: 64 (31%)
Diabetic control Controlled: 64 (31.2%)
Uncontrolled: 141 (68.8%)
Education status Low: 36 (18%)
Moderate: 132 (65%)
High: 35 (17%)
Life style Low: 69 (35.0%)
Moderate: 113 (57.4%0)
Good: 15 (7.6%)
Physical exercise Yes: 93 (47.9%)
No: 101 (52.1%)
Family history of DM First degree: 108 (36.5%)
Second degree: 137 (46.3%)
No: 51 (17.2%)
Family history of CVD Yes: 26 (14.1%)
No: 159 (85.9%)
Cholesterol lowering agent Yes: 84 (47.2%)
No: 94 (52.8%)
Table 2: Study parameters in case and control groups.
Parameter Case (Mean±SD) Control (Mean ± SD) P-value
hs-CRP (mg/l) 4.83 ± 0.42 3.48 ± 0.38 0.020
TG (mg/dl) 117 ± 48.3 114 ± 60.4 0.620
T.Cholestrol (mg/dl) 171 ± 33.7 163 ± 42.2 0.055
HDL-Cholestrol (mg/dl) 39.4 ± 8.88 45.2 ± 12.4 0.000
LDL-Cholestrol (mg/dl) 101 ± 35.8 103 ± 31.1 0.647
The results expressed as (Mean ± SD) and P value less than 0.05 was statistically
considered significant
Table 3: Biochemical parameters according to gender.
Parameters Male (Mean±SD) Female (Mean±SD) P-value
hs-CRP (mg/l) 3.54 ± 2.55 5.91 ± 2.61 0.005
TG (mg/dl) 119 ± 60.2 121 ± 62.7 0.794
T.Cholestrol (mg/dl) 150 ± 39.1 171 ± 40.1 0.000
HDL-Cholestrol (mg/dl) 37.1 ± 7.51 41.4 ± 9.49 0.000
LDL-Cholestrol (mg/dl) 91.3 ± 34.5 109 ± 35.0 0.000
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The results expressed as (Mean ± SD) and P-value less than 0.05 was statistically
considered significant.












hs-CRP (mg/l) 3.52 ± 3.23 4.98 ± 5.43 0.030
TG (mg/dl) 121 ± 69.1 125 ± 58.8 0.706
T.Cholestrol (mg/dl) 146 ± 38.2 176 ± 40.7 0.000
HDL-Cholestrol (mg/dl) 38.8 ± 8.71 39.0 ± 8.35 0.847
LDL-Cholestrol (mg/dl) 85.8 ± 32.1 114 ± 33.9 0.000
The results expressed as (Mean ± SD) and P-value less than 0.05 was statistically
considered significant.
Table 5: Correlation of biochemical parameters with study variables.
Correlation R P-value
hs-CRP with BMI 0.56** 0.000
hs-CRP with age -0.12 0.094
hs-CRP with duration -0.01 0.942
TG with BMI 0.37* 0.017
TG with age 0.02 0.800
TG with duration 0.07 0.355
T.Cholestrol with BMI 0.07 0.332
T.Cholestrol with age -0.08 0.250
T.Cholestrol with duration 0.50 0.484
HDL-C with BMI -0.36* 0.029
HDL-C with age -0.03 0.725
HDL-C with duration 0.05 0.505
LDL-C with BMI 0.06 0.428
LDL-C with age -0.11 0.110
LDL-C with duration 0.04 0.599
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(R): Pearson correlation test, (___): negative correlation, P-value less than 0.05 was
statistically considered significant.
 
Figure 1: Dot blots regression of hs-CRP with BMI, TG with BMI and HDL-C with BMI. R= Pearson correlation
test. (___): negative correlation P-value less than 0.05 were statistically considered significant.
5. Discussion
In this study we found that, type 2 DM was common in female than male. The pre-
dominance of females with diabetes is attributed to the hormonal effects, higher ability
of the body to store iron and physical inactivity indeed most of them were house-
wives [19]. In our study the majority of patients are elderly and overweight. Thus
postulated combination of genetic predisposition, environmental, nutritional factors,
obesity, physical inactivity, stress, and aging [20], might be involved in Sudanese
type2 DM. Moreover, characteristic data revealed significant higher of uncontrolled
DM patients and lower socioeconomic status. Previous study associated between low
educational level correlate with DM, and socioeconomic status inversely associated
with DM prevalence [21].
Serum hs-CRP level was significantly higher in type 2 DM patients versus controls.
Our results was in agreement with others that, pro-inflammatory cytokine hs-CRP was
significantly higher in type 2 diabetic patients [22, 23]. Recently, the inflammatory
pathway play critical role in type 2 pathogenesis, development and progression of
the diabetes complications [11]. On the other hand, accordance to previous reports
[24, 25], we found that, women had higher hs-CRP levels than with men. This sex
difference is incompletely understood, many studies speculated that, adiposity and
hormone replacement therapy or that looked only at postmenopausal women still found
higher levels of CRP in women [25].
In addition, the results of lipid profile showed insignificant difference in TG, TC and
LDL-C levels in patient and control groups. Previous study reported that, the mean TG,
TC and LDL-C concentrations were insignificantly differ in type 2 DM and control subject
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[26]. HDL-C level is significantly lower in type 2 DM patients as in line with previous study
noted that, type 2 patients had lower level of HDL-C compared with control participants.
In lipids metabolism in DM patients have reported that, decreasing in HDL-C may be
due to a reduction in lipoprotein lipase (LPL) activity, which would impair the maturation
of HDL particles. In type 2 DM, particularly in poor glycemic control patients who are
relatively insulin deficient, LPL activity is decreased [27]. Furthermore female type 2
DM patients had higher levels of TC, HDL-C and LDL-C than diabetic male which is
in line with previous studies [28], which attributed to the effect of sex hormones and
distribution of body fat leading to these differences [28].
Moreover patients received Statin treatment revealed lower levels of hs-CRP, TC and
LDL-C. Previous evidence indicating that, treatment with atorvastatin lead to reduce
LDL-C and hs-CRP levels in patients with type 2 DM [29].
Likewise to previous reports stated that, hs-CRP level is correlate positively with BMI
[30]. In addition, the correlation between serum TG and BMI observed the highest
triglyceride levels in overweight and obese patients [31] while HDL-C was negatively
correlate with BMI [32], our study showed BMI correlate positively with TG and hs-CRP,
while it correlated negatively with HDL-C.
6. Conclusion
The study concluded that, hs-CRP had significantly higher in type 2 DM patients.
BMI positively associated with hs-CRP and TG while negatively correlate with HDL-C.
Therefore, hs-CRP is useful diagnostic predictor marker for CVD in type 2 DM patients.
Therefore, periodic monitoring should recommended especially for overweight and
obese type 2 DM patients.
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